These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17531196)

  • 41. [Preparation and characterization of recombinant retroviral vector containing t-PA cDNA].
    Cui N; Peng L; Song H; Han Q; Chen H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Mar; 11(1):50-2. PubMed ID: 15619905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of recombinant norovirus-like particles (VLP) in the human endothelial kidney cell line 293T.
    Taube S; Kurth A; Schreier E
    Arch Virol; 2005 Jul; 150(7):1425-31. PubMed ID: 15789263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Viral vectors for the expression of proteins in plants.
    Gleba Y; Klimyuk V; Marillonnet S
    Curr Opin Biotechnol; 2007 Apr; 18(2):134-41. PubMed ID: 17368018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A vaccinia replication system for producing recombinant hepatitis C virus.
    Wu YS; Feng Y; Dong WQ; Zhang YM; Li M
    World J Gastroenterol; 2004 Sep; 10(18):2670-4. PubMed ID: 15309717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Up-regulation of hepatitis C virus replication and production by inhibition of MEK/ERK signaling.
    Ndjomou J; Park IW; Liu Y; Mayo LD; He JJ
    PLoS One; 2009 Oct; 4(10):e7498. PubMed ID: 19834602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins.
    Ishii K; Murakami K; Hmwe SS; Zhang B; Li J; Shirakura M; Morikawa K; Suzuki R; Miyamura T; Wakita T; Suzuki T
    Biochem Biophys Res Commun; 2008 Jul; 371(3):446-50. PubMed ID: 18445476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression and self-assembly of HCV structural proteins into virus-like particles and their immunogenicity.
    Zhao W; Liao GY; Jiang YJ; Jiang SD
    Chin Med J (Engl); 2004 Aug; 117(8):1217-22. PubMed ID: 15361298
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studying HCV cell entry with HCV pseudoparticles (HCVpp).
    Bartosch B; Cosset FL
    Methods Mol Biol; 2009; 510():279-93. PubMed ID: 19009269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and characterization of a recombinant cDNA-based hepatitis C virus system.
    Ndjomou J; Liu Y; O'Malley J; Ericsson M; He JJ
    Biochem Biophys Res Commun; 2007 Jul; 359(1):57-62. PubMed ID: 17531196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture.
    Bartenschlager R
    Curr Opin Microbiol; 2006 Aug; 9(4):416-22. PubMed ID: 16814596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
    Gottwein JM; Bukh J
    Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assembly of hepatitis C virus particles.
    Suzuki T
    Microbiol Immunol; 2011 Jan; 55(1):12-8. PubMed ID: 21175769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation systems for anti-HCV drugs.
    Moriishi K; Matsuura Y
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.